$3.5T
Total marketcap
$112.86B
Total volume
BTC 60.78%     ETH 9.05%
Dominance

Moderna MRNA Stock

26.07 USD {{ price }} -2.578477% {{change_pct}}%
Exchange
NasdaqGS
Market Cap
10.08B USD
LOW - HIGH [24H]
25.98 - 26.77 USD
VOLUME [24H]
5.5M USD
{{ volume }}
P/E Ratio
0
Earnings per share
-8.73 USD

Moderna Price Chart

Moderna MRNA Financial and Trading Overview

Moderna stock price 26.07 USD
Previous Close 126.05 USD
Open 126 USD
Bid 0 USD x 900
Ask 0 USD x 800
Day's Range 125.08 - 130.19 USD
52 Week Range 115.03 - 217.25 USD
Volume 3.02M USD
Avg. Volume 3.31M USD
Market Cap 49.55B USD
Beta (5Y Monthly) 1.697464
PE Ratio (TTM) 10.904362
EPS (TTM) -8.73 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 215.93 USD

MRNA Valuation Measures

Enterprise Value 41.73B USD
Trailing P/E 10.904362
Forward P/E -29.743708
PEG Ratio (5 yr expected) 1.29
Price/Sales (ttm) 3.2903607
Price/Book (mrq) 2.6460648
Enterprise Value/Revenue 2.771
Enterprise Value/EBITDA 8.066

Trading Information

Moderna Stock Price History

Beta (5Y Monthly) 1.697464
52-Week Change 1.52%
S&P500 52-Week Change 20.43%
52 Week High 217.25 USD
52 Week Low 115.03 USD
50-Day Moving Average 134.68 USD
200-Day Moving Average 152.95 USD

MRNA Share Statistics

Avg. Volume (3 month) 3.31M USD
Avg. Daily Volume (10-Days) 2.82M USD
Shares Outstanding 381.21M
Float 344.06M
Short Ratio 5.44
% Held by Insiders 9.60%
% Held by Institutions 68.32%
Shares Short 18.72M
Short % of Float 6.52%
Short % of Shares Outstanding 4.90%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 31.76%
Operating Margin (ttm) 32.05%
Gross Margin 39.81%
EBITDA Margin 34.35%

Management Effectiveness

Return on Assets (ttm) 11.66%
Return on Equity (ttm) 26.62%

Income Statement

Revenue (ttm) 15.06B USD
Revenue Per Share (ttm) 38.61 USD
Quarterly Revenue Growth (yoy) -69.29%
Gross Profit (ttm) 10.55B USD
EBITDA 5.17B USD
Net Income Avi to Common (ttm) 4.78B USD
Diluted EPS (ttm) 11.92
Quarterly Earnings Growth (yoy) -97.79%

Balance Sheet

Total Cash (mrq) 8.92B USD
Total Cash Per Share (mrq) 23.41 USD
Total Debt (mrq) 1.11B USD
Total Debt/Equity (mrq) 5.87 USD
Current Ratio (mrq) 3.464
Book Value Per Share (mrq) 49.122

Cash Flow Statement

Operating Cash Flow (ttm) 993M USD
Levered Free Cash Flow (ttm) 541.88M USD

Profile of Moderna

Country United States
State MA
City Cambridge
Address 200 Technology Square
ZIP 02139
Phone 617 714 6500
Website https://www.modernatx.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 3900

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV+PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella-zoster virus, and human immunodeficiency virus vaccines; and public health vaccines consists of Zika and Nipah vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; localized regenerative, systemic intracellular, and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Q&A For Moderna Stock

What is a current MRNA stock price?

Moderna MRNA stock price today per share is 26.07 USD.

How to purchase Moderna stock?

You can buy MRNA shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Moderna?

The stock symbol or ticker of Moderna is MRNA.

Which industry does the Moderna company belong to?

The Moderna industry is Biotechnology.

How many shares does Moderna have in circulation?

The max supply of Moderna shares is 386.74M.

What is Moderna Price to Earnings Ratio (PE Ratio)?

Moderna PE Ratio is now.

What was Moderna earnings per share over the trailing 12 months (TTM)?

Moderna EPS is -8.73 USD over the trailing 12 months.

Which sector does the Moderna company belong to?

The Moderna sector is Healthcare.

Moderna MRNA included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
NASDAQ Composite IXIC 19100.94 USD
-0.51
7.27B USD 19084.38 USD 19276.83 USD 7.27B USD
S&P 500 (Yahoo.com) GSPC 5888.55 USD
-0.56
2.55B USD 5881.88 USD 5939.92 USD 2.55B USD
S&P 500 INDEX SPX 5891.4 USD
-0.51
1.91B USD 5889.89 USD 5939.92 USD 1.91B USD
US100 NDX 21318.17 USD
-0.45
1.07B USD 21296.51 USD 21508.08 USD 1.07B USD
Nasdaq US CapEx Achievers Index CAPEXA 2869.47 USD
-0.64
2865.51 USD 2896.68 USD
NASDAQ Global Select Market Com NQGS 9347.78 USD
-0.51
9339.71 USD 9434.23 USD
NASDAQ DM Ex Japan Large Mid Ca NQDMXJPLMAUD 2100.38 AUD 1390.15 USD
<0.01
2100.38 AUD 1390.15 USD 2100.38 AUD 1390.15 USD
Nasdaq-100 ESG Net Notional Tot NDXESG24 1675.5 EUR 1831.55 USD
-0.13
1675.33 EUR 1831.36 USD 1690.89 EUR 1848.37 USD
NASDAQ-100 Equal Weighted NDXE 7934.58 USD
-0.67
7927.04 USD 8010.71 USD
Nasdaq-100 Notional Net Return XNDXNNREUR 3925.31 EUR 4290.89 USD
-0.1
3924.67 EUR 4290.19 USD 3960.43 EUR 4329.29 USD
Stlmt ID NASDAQ Biotechnology NBX 3995.9 USD
-4.37
4555.41 USD 4917.8 USD
Nasdaq-100 Micro Index XND 213.18 USD
-0.45
212.97 USD 215.08 USD
NASDAQ-100 Pre Market Indicator QMI 21437.38 USD
+0.1
21437.4 USD 21479.5 USD
NASDAQ-100 Reduced Value Index NQX 4263.63 USD
-0.45
4259.3 USD 4301.62 USD
NASDAQ Global BuyBack Achievers DRBG 2379.18 USD
-0.77
2377.06 USD 2397.75 USD
Nasdaq US Price Setters Index NQPRCE 2913.96 USD
-0.76
2911.87 USD 2941.46 USD
Nasdaq AlphaDEX Multi Cap Growt NQDXUSMLTCG 2975.54 USD
-0.71
2973.25 USD 2998.85 USD
NASDAQ-100 Ex-Tech Sector NDXX 5843.23 USD
-0.42
5836.04 USD 5881.79 USD
Nasdaq-100 ESG JPY Index NDXESG07 2053.8 JPY 13.86 USD
-0.14
2051.92 JPY 13.85 USD 2073.53 JPY 14 USD
NASDAQ-100 PM Settlement Value XQC 16331.98 USD
+1.13
16331.98 USD 16331.98 USD